Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Inflammopharmacology
|
March 24, 2004
Mechanisms of action of paracetamol and related analgesics
Garry G Graham, Kieran F Scott
American Journal of Therapeutics
|
January 22, 2005
Mechanism of action of paracetamol
Garry G Graham, Kieran F Scott
Inflammopharmacology
|
September 12, 2021
Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs
Garry G Graham, Kieran F Scott
Drug Safety
|
March 1, 2005
Tolerability of paracetamol
Garry G Graham, Kieran F Scott, Richard O Day
Biochimica Et Biophysica Acta
|
January 8, 2008
Antibacterial actions of secreted phospholipases A2. Review
Timo J Nevalainen, Garry G Graham, Kieran F Scott
Inflammopharmacology
|
September 17, 2021
Honorary Professor Garry Graham
Richard O Day, Kenneth M Williams, Kieran F Scott
Drugs
|
February 5, 2004
[Tolerability of paracetamol]
Garry G Graham, Kieran F Scott, Richard O Day
Expert Opinion on Therapeutic Targets
|
June 5, 2003
Secreted phospholipase A2 enzymes as therapeutic targets
Kieran F Scott, Garry G Graham, Katherine J Bryant
Prostate Cancer
|
January 18, 2013
Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology
Brian W C Tse, Kieran F Scott, Pamela J Russell
Inflammopharmacology
|
May 31, 2013
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings
Garry G Graham, Michael J Davies, Richard O Day, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Inflammopharmacology
|
March 24, 2004
Mechanisms of action of paracetamol and related analgesics
Garry G Graham, Kieran F Scott
American Journal of Therapeutics
|
January 22, 2005
Mechanism of action of paracetamol
Garry G Graham, Kieran F Scott
Inflammopharmacology
|
September 12, 2021
Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs
Garry G Graham, Kieran F Scott
Drug Safety
|
March 1, 2005
Tolerability of paracetamol
Garry G Graham, Kieran F Scott, Richard O Day
Biochimica Et Biophysica Acta
|
January 8, 2008
Antibacterial actions of secreted phospholipases A2. Review
Timo J Nevalainen, Garry G Graham, Kieran F Scott
Inflammopharmacology
|
September 17, 2021
Honorary Professor Garry Graham
Richard O Day, Kenneth M Williams, Kieran F Scott
Drugs
|
February 5, 2004
[Tolerability of paracetamol]
Garry G Graham, Kieran F Scott, Richard O Day
Expert Opinion on Therapeutic Targets
|
June 5, 2003
Secreted phospholipase A2 enzymes as therapeutic targets
Kieran F Scott, Garry G Graham, Katherine J Bryant
Prostate Cancer
|
January 18, 2013
Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology
Brian W C Tse, Kieran F Scott, Pamela J Russell
Inflammopharmacology
|
May 31, 2013
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings
Garry G Graham, Michael J Davies, Richard O Day, et al.
Page
of 5